The first AbCellera Biologics trade was made in Q2 2021.
Since then Joel Greenblatt bought shares four more times and sold shares on four occasions. The investor completely sold their stake between Q2 2023 and Q3 2023.
Avg closing price
Price range
Sold -46.1 Thousand shares
Q3 2023
Avg closing price
$6.08
Price range
$4.60
-
$7.95
Sold 62.6% shares (-77.2 Thousand shares)
Q2 2023
Avg closing price
$6.82
Price range
$5.66
-
$7.59
Increased shares by 6.2% (+7.16 Thousand shares)
Q1 2023
Avg closing price
$9.08
Price range
$7.31
-
$11.18
Increased shares by 47.6% (+37.5 Thousand shares)
Q4 2022
Avg closing price
$11.55
Price range
$9.48
-
$14.52
New holding (+78.6 Thousand shares)
Q3 2022
Avg closing price
$10.97
Price range
$9.20
-
$13.68
Sold -28.4 Thousand shares
Q1 2022
Avg closing price
$9.47
Price range
$7.46
-
$14.14
Sold 61.1% shares (-44.7 Thousand shares)
Q4 2021
Avg closing price
$15.18
Price range
$12.99
-
$17.73
Increased shares by 186.7% (+47.6 Thousand shares)
Q3 2021